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It is well-known that the morphological variability of mucoepidermoid carcinoma (MEC) of the salivary glands may lead to
interpretative diﬃculties on ﬁne-needle aspiration (FNA) diagnosis. In this study we identify morphologic features that may be
useful in the FNA diagnosis of MEC. The cohort included 23 cases of MEC; cytology and histology slides were reviewed and
assessedfor% cysticcomponent,extracellular mucin,mucousandintermediate cells, oncocytes, cells withfoamy/clearcytoplasm,
keratinized cells and lymphocytes. On FNA 12/23 (52%) cases were diagnosed as consistent with or suggestive of MEC; 6/23
(26%) as salivary gland neoplasm and 5/23 (22%) as no tumor seen. The cystic component was ≥50% in 18/23 (78%) and <50%
in 5 cases. The features prevalent in FNA and histology were: mucous cells (96% and 91%), extracellular mucin (91% both),
intermediate cells (100 and 83%), lymphocytes (96 and 78%) and cells with foamy/clear cytoplasm (74% both). Oncocytes were
seen in 43 and 22% and keratinized cells in 48 and 13% cases. Cases with oncocytes and lymphocytes were interpreted as favor
Warthin’s tumor on FNA. Presence of mucous cells, cells with foamy/clear cytoplasm, intermediate cells and lymphocytes in a
mucinous background are diagnostic indicators of MEC; presence of oncocytes should not refrain from diagnosing MEC in FNA
specimens.
1.Background
Fine needle aspiration (FNA) of salivary gland lesions is
a valuable tool to pre-operatively diagnose/assess lesional
tissue,determinetheneedforsurgicalinterventionandassist
in planning the appropriate surgical approach prior to resec-
tion. This technique is safe and eﬀective with some studies
demonstrating overall sensitivity, speciﬁcity and accuracy
of 92%, 100%, and 98%, respectively [1–6]; however, the
employment of FNA to diagnose mass lesions of the salivary
glands remains controversial [1, 6]. The proponents believe
that it can provide accurate diagnosis in many common
tumors such as pleomorphic adenoma, distinguish benign
from malignant lesions and prevent surgical intervention
in cases with inﬂammatory lesions, lymphoma and certain
metastatic tumors. The opponents of the use of FNA in
salivary gland lesions believe that this procedure carries a
high false negative rate and may fail to diagnose speciﬁc
type of tumor. Many studies have shown that the latter is
most likely due to the inherent morphologic variability that
is, overlapping architectural patterns and nuclear cytology
seen within these tumors, which can lead to interpretative
diﬃculties on cytologic examination [1, 2, 7–10].
Mucoepidermoid carcinoma (MEC) is the most com-
mon malignant neoplasm of the salivary gland origin and
accounts for 5% to 10% of all salivary gland neoplasms [11].
The majority of MEC occur in the parotid gland resulting
in accessibility to biopsy by FNA; however, at times the
diagnosis of MEC (mainly low-grade tumors by FNA) can
be diﬃcult due to overlapping cytomorphology with benign
lesions [2, 3, 7, 8, 12, 13]. Therefore, given the common
occurrence and heterogeneity of MEC, proper sampling and
awareness of its morphologic complexity is critical to an
accurate diagnosis.
The diﬃculty in the cytologic diagnosis of MEC is re-
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High grade neoplasms are more easily recognizable as
malignant and, therefore, more likely to receive the appro-
priatepreoperativemanagement[11].Bycontrast,low-grade
neoplasms are less easily recognizable as malignant and,
therefore, under-diagnosis could result in treatment delays
orinappropriatepre-operativemanagement [14].Numerous
of grading schemes have been devised to diﬀerentiate
between low, intermediate, and high-grade MEC [11, 14]. A
scheme, proposed by Brandwein et al., assigned a numerical
score to speciﬁc histologic features and adding these scores
to determine the histologic grade. The accumulation of
malignant features such as (tumor-type necrosis, nuclear
pleomorphism, and high mitotic activity) results in a higher
score [11]. Given the consequences of under-diagnosing
MEC (such as treatment delays or inappropriate surgical
approach), and the challenges of diagnosing MEC by cytol-
ogy, in this study we attempt to identify the morphologic
features that may be most useful in the FNA diagnosis of
MEC, particularly of low-grade neoplasms.
2.Materialsand Methods
Inthisretrospectivestudy,23casesofMECwithpreoperative
FNA, were evaluated. The patient’s ranged in age from
18 to 79 years and received surgical care at the Hospital
of the University of Pennsylvania between 1995 and 2008.
Cytology and histology slides and clinicopathologic features
were reviewed in each case. The cases were assessed for
the following features: % cystic component, nuclear atypia,
necrosis, extracellular mucin, mucuscells, intermediate cells,
oncocytes, and cells with foamy/clear cytoplasm, keratinized
cells and lymphocytes. A histologic grade of low, interme-
diate or high was assessed in each case. The morphologic
features noted by cytologic examination were compared to
the original cytologic diagnosis in an eﬀort to assess which
features were the most consistent/reproducible in providing
an accurate cytologicdiagnosis and which histomorphologic
features were associated with under-diagnosis of MEC by
cytologic examination.
3.Results
In this study, 22/23 (96%) of, MECs arose in the parotid
gland (average size 1.9cm) and one (4%) from a minor
s a l i v a r yg l a n di nt h et o n g u e .O nF N A ,7 / 2 3( 3 0 % )c a s e s
were diagnosed as consistent with, 5/23 (22%) as suggestive
of MEC; 6/23 (26%) as salivary gland neoplasm and 5/23
(22%)asnotumorseen.Inthesix casesdiagnosedas salivary
gland neoplasm on FNA, two were diagnosed as favor acinic
cell carcinoma (2/6), two were diagnosed as favor Warthin
tumor (2/6),one was diagnosed as neoplasm with squamous
diﬀerentiation (1/6) and another was diagnosed as favor
benign mixed tumor versus mucoepidermoid carcinoma or
adenoid cystic carcinoma (1/6). On histologic examination,
the tumor grade was low in 13/23 (56%), intermediate 9/23
(39%) and high in 1/23 (4%) cases; neural invasion was
seen in 4/23 (17%) and lymph node metastasis in 1/23 (4%)
cases. The cystic component was ≥50% in 18/23 (78%) cases
(see Tables 1 and 3). The morphologic features prevalent in
both histology and FNA specimens included: mucus cells
(96 and 91%), presence of extracellular mucin (91% both),
intermediate cells (100 and 83%), lymphocytes (96 and
78%), and cells with foamy/clear cytoplasm (73% both).
Oncocyticcellswere seenin43and 22%and keratinizedcells
in 48 and 13% cases (see Table 2).
An intraoperative frozen section was performed in 9/23
(39%)cases.Thefrozensectiondiagnoseswere:MEC4cases,
low-grade carcinoma 1, adenocarcinoma 1, consistent with
Warthin tumor 1, cystic neoplasm 1, and no tumor seen 1
case.TheaveragetimeintervalbetweenFNAand surgerywas
5weeks in 12cases diagnosed asconsistent with orsuggestive
o fM E C .T h ea v e r a g et i m ei n t e r v a lw a s4w e e k si n6c a s e s
diagnosed as salivary gland neoplasm and 22 weeks in cases
where FNA failed to identify tumor (see Tables 1 and 3).
4.Discussion
Mucoepidermoid carcinoma is the most common malignant
salivary gland tumor. It is usually composed of varying
amounts of epidermoid (squamoid) cells, intermediate cells,
and mucocytes (often seen lining the microcysts). The
combination of these cellular elements in varying pro-
portions can lead to complex histologic patterns causing
diagnostic challenges [11, 12]. The MEC are usually graded
as low grade/welldiﬀerentiated (tumor exhibiting greater
than 50% of mucous elements), intermediate grade (10–
50% of mucous elements and high grade (less than 10% of
mucous elements). The histopathologic grading is usually
used as the main prognostic indicator; however, some of the
low-grade tumors can follow an aggressive clinical course
[11, 14–18]. Furthermore, some experts believe that a tumor
grading system of low and high grade is more reproducible
as compared to the 3 category system [11].
Similar to histology, the diagnosis of low-grade MEC by
FNA can be challenging due to spatial heterogeneity and
multiple histologic components. Therefore, adequate sam-
pling of various components within the tumor is essential to
arrive at correct diagnosis [7, 12].
In our study, the morphologic features most prevalent in
both the cytologic and histologic specimens of MEC were
mucus cells (pseudo-goblet cells) and presence of extracel-
lular mucin (both >90%). In addition, intermediate cells
(100% in histology and 83% in cytology) and lymphocytes
(96% in histology and 78% in cytology)were also commonly
noted. The presence of oncocytic cells (43% in histology and
22% in cytology) and squamous/epidermoid cells (48% in
histology and 13% in cytology) were less commonly seen.
Oncocytic cells were seen 10/23 (43%) cases in histology
and 5/23 (22%) of cytology cases. One case with oncocytic
cells was interpreted on FNA as “salivary gland neoplasm
favor Warthin tumor”, 2 as MEC, 1 as acinic cell carcinoma
and 1 as suggestive of MEC. On re-review, all contained
varying amounts of extracellular mucin, mucous cells and
intermediate cells; pseudo-goblet cells/clear cells were seen
in 3 cases. The case originally classiﬁed as Warthin tumors
alsocontainedanexcessoflymphocytes.OncocyticcellshavePathology Research International 3
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Figure 1: (a and b): High-power magniﬁcation of a Diﬀ-Quik stained FNA specimen of low-grade mucoepidermoid carcinoma showing
histiocyte-like (clear) cells with vacuolated cytoplasm (a) and fragments of glandular-type cells (b). (c and d) High-power magniﬁcation
of H&E stained histologic section of a low-grade mucoepidermoid carcinoma showing glandular-type (mucous) cells lining a microcyst (c)
and a cluster of histiocyte-like (clear) cells (d).
Table 1: Clinicopathologicdata on 23 patients with mucoepidermoid carcinoma.
FNA-Dx % cases Gender
(M:F)
Avg-Age
(yrs)
Avg-Size
(cm) Location Avg-time between
FNA & resection
CW/SO MEC
(12/23) 52% 8:4 49 1.6 11/12 parotid,
1t o n g u e 5 weeks
SGN (6/23) 26% 4:2 52 2.5 6/6 parotid 4 weeks
Neg or inﬂamm
(5/23) 22% 1:4 50 1.6 5/5 parotid 22 weeks
Dx:Diagnosis, Avg:Average, CW:Consistentwith, SO:Suggestive of, SGN:salivary gland neoplasm, Neg:Negative, Inﬂamm:Inﬂammatory.
Table 2: Key morphologic features observed in histology and FNA specimens.
Cell type observed % in Histology % in FNA
Mucous (pseudogoblet) cells (22/23) 96% (21/23) 91%
Lymphocytes (22/23) 96% (18/23) 78%
Clear cells (17/23) 74% (17/23) 74%
Intermediate cells (23/23) 100% (19/23) 83%
Keratinized squamous cells (11/23) 48% (3/23) 13%
Oncocytes (10/23) 43% (5/23) 22%4 Pathology Research International
(a) (b)
(c) (d)
Figure 2: (a and b): Low-power magniﬁcationof a Diﬀ-Quik stained FNA specimen showing oncocytic fragments present in a background
lymphocytes (mistakeninterpreted asWarthin’stumor) andhigh-powermagniﬁcationofoncocyticfragmentsintermixedwithlymphocytes.
(c and d): Low-power magniﬁcation of H&E stained histologic section of a low-grade mucoepidermoid carcinoma showing a numerous
cysticspacelinedbyoncocyticepithelium inabackgroundofreactivelymphoidfollicles(c)andhigh-powermagniﬁcationshowsamicrocyst
lined by oncocytes and mucous cells (this case was misinterpreted as Warthins tumor on frozen section) (d).
Table 3: Cytologic/Histologic diagnosis comparison.
FNA DX (23 cases) FS DX (9/23 cases) Histologic grade
C/W MEC (7/23)
MEC (3/5) LGMEC (2/7)
Adenocarcinoma (1/5) IGMEC (4/7)
Cystic Neop with papillary-features (1/5) HGMEC (1/7)
S/O MEC (5/23) SO MEC (1/2) LGMEC (3/5)
NTS (1/2) IGMEC (2/5)
SGN: (6/23) None performed
Favor WT (2/6) LGMEC (1/2)
IGMEC (1/2)
Favor ACC(2/6) LGMEC (2/2)
Favor BMT versus MEC or ADCC (1/6) LGMEC (1/1)
Neop with squ-feat (1/6) IGMEC (1/1)
Neg or inﬂamm (5/23) LG-CA (1/2) LGMEC (4/5)
WT (1/2) IGMEC (1/5)
Dx:Diagnosis, Avg:Average, CW:Consistentwith, SO:Suggestive of, SGN:salivary gland neoplasm, Neg:Negative, Inﬂamm:Inﬂammatory.Pathology Research International 5
been reported to occur in MEC; in addition, a rare variant
of MEC known as oncocytic MEC has been described [19–
22].Thesetumorsarecomposedexclusivelyofoncocyticcells
arranged in nests and sheets in sclerotic stroma with variable
number of chronic inﬂammatory cells [22]. The majority
of the oncocytic MEC described in the literature lack or
contain minimal squamous/epidermoid cells. On re-review
we believe,based onthe criteria described by Weinreb et.al, 5
of 10 cases represent MEC containing oncocytic cells as one
the cellular components while 5 of 10 cases represent true
oncocytic variant of MEC [22].
We believe that the most helpful features in diﬀerentiat-
ingMECcontainingoncocyticcellsfromothersalivary gland
lesions in FNA specimens is the presence of extracellular
mucin, mucous cells and pseudo-goblet/clearcells.
Since a major diﬃculty in utilizing FNA to diagnose
MEC is related to sampling, [7, 12] we believe it is most
useful to identify various cellular and acellular components
and formulate a diﬀerential diagnosis based on a few
criteria including: nuclear atypia, metaplastic changes/cell
type present (squamous, oncocytic, basal, or myoepithelial
cells), presence or absence of lymphocytes, and presence
of extracellular material (necrotic debris, chondromyxoid
matrix or Mucin). Given the overlapping morphologic
features of many salivary gland neoplasms, immunostains
are rarely useful in diﬀerentiating the various salivary gland
neoplasms [7, 23].
To add to these challenges, it has been shown that
metaplastic/reparative changes can occur in benign sali-
vary gland neoplasms due to physical trauma induced by
FNA [24]. These changes include squamous metaplasia,
infarction and necrosis, subepithelial stromal hyalinization,
acute and chronic hemorrhage, inﬂammation with mult-
inucleated giant cells, granulation tissue with subsequent
ﬁbrosis; cholesterol cleft formation, pseudoxanthomatous
reaction, and microcystic degeneration. Thus, a repeat
FNA of a salivary gland lesion containing above-mentioned
reactive/reparative changes can pose an even greater chal-
lenge to the cytopathologist in the diagnosis of low-grade
mucoepidermoid carcinoma; therefore, most clinicians will
recommend surgery after an FNA diagnosis of salivary gland
neoplasm [24].
Severalstudieshavediscussedtheutilityofintraoperative
consultation in the surgical management of salivary gland
lesions. Studies from our institution have shown that the
diagnostic accuracy of FNA and frozen section are compa-
rable for the interpretation of salivary gland neoplasms, and
the accuracy of both is increased when used in conjunction
[6]. In the current study, 12/23 (52%) cases were diagnosed
as either consistent with or suggestive of MEC and 6/23
(26%) cases as salivary gland neoplasm. An intraoperative
frozen section was performed in 9/23 (39%) cases, and of
these, 8 (89%) cases were classiﬁed either as carcinoma
or neoplasm (MEC 3, low-grade carcinoma 1, suggestive
of MEC 1, adenocarcinoma 1, consistent with Warthin
tumor 1, cystic neoplasm 1 and no tumor seen 1 case).
Based on these data, the diagnostic accuracy of FNA is
close to that of frozen section for the diagnosis of salivary
gland neoplasms (78% (18/23) versus 89% (8/9)) and
carcinomas (52% (12/23) versus 67% (6/9)). These ﬁndings
support, as suggested by other authors, the combined use of
intraoperative frozen section with FNA in the evaluation of
salivary gland neoplasms [6].
5.Conclusions
We believe that the cytologic diagnosis of low-grade MEC
remains challenging due to overlapping cytomorphologic
features seen in other salivary gland lesions. Among the
many cytologic features described, presence of extracellular
mucin, mucous cells, and intermediate cells should raise the
suspicion of MEC. In addition, oncocytic cells can occur
in varying proportions in some cases of MEC and in the
presence of above-mentioned features should not dissuade
one from making or suggesting a diagnosis of this tumor in
FNA specimens.
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